NHS
Neuberger High Yield Strategies Fund Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHS
this stock
Neuberger High Yield Strategies Fund Inc.
|
$259.92M | -13.4% | — | — | 0.1% |
|
BLK
BlackRock, Inc.
|
$162.29B | -6.5% | +16.2% | 26.3 | 1.3% |
|
BX
Blackstone Inc.
|
$150.21B | -19.4% | +9.2% | 51.9 | 2.7% |
|
BN
BROOKFIELD Corp /ON/
|
$97.01B | -5.2% | — | — | 0.6% |
|
KKR
KKR & Co. Inc.
|
$87.50B | -26.3% | -11.0% | — | 1.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHS | +1.6% | -2.1% | -13.1% | -0.5% | -13.4% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +0.2% | -0.8% | -21.2% | -0.2% | -22.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.